Benzinga | Feb 17, 2021 06:04AM EST

SVB Leerink Maintains Outperform on Exact Sciences, Raises Price Target to $180

SVB Leerink analyst Puneet Souda maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $170 to $180.